Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites
Author Information
Author(s): Selvapandiyan Angamuthu, Dey Ranadhir, Gannavaram Sreenivas, Lakhal-Naouar Ines, Duncan Robert, Salotra Poonam, Nakhasi Hira L.
Hypothesis
Can genetically altered live-attenuated parasites provide effective immunity against visceral leishmaniasis?
Conclusion
Genetically defined live-attenuated Leishmania donovani parasites may serve as effective vaccine candidates against visceral leishmaniasis.
Supporting Evidence
- Individuals who recover from natural infection develop life-long protection against reinfection.
- Genetically altered parasites can evoke a protective immune response similar to natural infection.
- Live-attenuated vaccines have been successfully used against various viral and bacterial pathogens.
Takeaway
Scientists are trying to create a vaccine for a disease called leishmaniasis by using special parasites that are changed to be less harmful but still help the body remember how to fight the disease.
Methodology
The study discusses the development and characteristics of genetically altered, live-attenuated Leishmania donovani parasites and their potential use as vaccine candidates.
Limitations
Concerns about the risk of reversion to virulence and the need for strict safety measures in vaccine development.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website